|
- ENHERTU® (fam-trastuzumab deruxtecan-nxki) Patient Website
How will I receive ENHERTU? You will receive ENHERTU into your vein through an intravenous (IV) line by your healthcare provider ENHERTU is given 1 time every three weeks (21-day treatment cycle) Your healthcare provider will decide how many treatments you need
- ENHERTU® (fam-trastuzumab deruxtecan-nxki) | Patient Site
Find valuable information about ENHERTU® (fam-trastuzumab deruxtecan-nxki), including clinical trial results, safety information, [downloadable resources,] and more
- HER2-positive mBC ENHERTU® (fam-trastuzumab deruxtecan-nxki)
What is ENHERTU? ENHERTU is a prescription medicine used to treat adults who have human epidermal growth factor receptor 2 (HER2)-positive breast cancer that cannot be removed by surgery or that has spread to other parts of the body (metastatic), and who have received a prior anti-HER2 breast cancer treatment: for metastatic disease, or
- ENHERTU® (fam-trastuzumab deruxtecan-nxki) | Results with ENHERTU
What is ENHERTU? ENHERTU is a prescription medicine used to treat adults who have human epidermal growth factor receptor 2 (HER2)-positive breast cancer that cannot be removed by surgery or that has spread to other parts of the body (metastatic), and who have received a prior anti-HER2 breast cancer treatment: for metastatic disease, or
- ENHERTU® (fam-trastuzumab deruxtecan-nxki) | Potential Side Effects
Find information about potential side effects that may happen with ENHERTU® (fam-trastuzumab deruxtecan-nxki) and tips to help manage these side effects with your doctor
- ENHERTU® (fam-trastuzumab deruxtecan-nxki) | About ENHERTU
ENHERTU is given as an intravenous (IV) infusion once every 3 weeks You will receive an ENHERTU infusion either at your oncologist's office or at a nearby infusion center
- ENHERTU® (fam-trastuzumab deruxtecan-nxki) | Patient Site
ENHERTU (en-HER-too) is a prescription medicine used to treat adults who have non-small cell lung cancer (NSCLC) that has a certain mutation in the HER2 gene and cannot be removed by surgery or has spread to other parts of your body (metastatic), and who have received a prior treatment
- ENHERTU® (fam-trastuzumab deruxtecan-nxki) | Support and Resources
What is ENHERTU? ENHERTU is a prescription medicine used to treat adults who have human epidermal growth factor receptor 2 (HER2)-positive breast cancer that cannot be removed by surgery or that has spread to other parts of the body (metastatic), and who have received a prior anti-HER2 breast cancer treatment:
|
|
|